Current Report Filing (8-k)
December 16 2019 - 8:28AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
December
16, 2019
TAURIGA
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Florida
|
|
000-53723
|
|
30-0791746
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
#)
|
|
(IRS
Employer
Identification
Number)
|
555
Madison Avenue, 5th Floor
New
York, NY
(Address
of principal executive office)
Tel:
(917) 796-9926
(Registrant’s
telephone number)
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2)
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $0.00001 per share
|
|
TAUG
|
|
OTCQB
|
Item
8.01 Other Events.
On
October 23, 2019, Tauriga Sciences, Inc. (OTCQB stock symbol: TAUG, the “Company”) had announced (through a press
release of same date) that it had been invited to present at The Investor Summit (the “Conference”) on December 17,
2019 at Hotel Monaco in Philadelphia, Pennsylvania; however, due to a since scheduled business meeting with an existing Company
distributor on the same date as the Conference, which involves the potential commercial sale of additional units of its flagship
product Tauri-Gum™, and the Company’s prioritization of driving its product sales revenues, it has canceled its presentation
at the Conference as a result of this scheduling conflict.
The
Company plans to present at a number of investor conferences, both domestic and international, over the course of 2020, and the
organizers of the Conference have agreed to apply the Company’s payment of its Conference fees to the spring 2020 summit
being held in New York City.
The
information in this Item 8.01 of this Current Report on Form 8-K is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Date:
December 16, 2019
TAURIGA
SCIENCES, INC.
|
|
|
|
|
By:
|
/s/
Seth M. Shaw
|
|
|
Seth
M. Shaw
|
|
|
Chief
Executive Officer
|
|
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2024 to May 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From May 2023 to May 2024